As a reminder, you must attend both days of the conference (Wednesday September 20th and Wednesday September 27th) and complete all required evaluations and steps to be eligible to receive continuing education credit. 

Presented by:

• STD/HIV Prevention Training Center at Johns Hopkins (STD/HIV PTC)
• Central East Addiction Technology Transfer Center (ATTC)- Danya Institute
• Rutgers Global Tuberculosis Institute
• MidAtlantic AIDS Education and Training Center (MAAETC) Howard University Regional Partner

These collaborative training centers are teaming up to bring you a free two-day training designed to increase your knowledge regarding tuberculosis, HIV, Sexually Transmitted Infections, Substance Use Disorders, and Mental Health.

Learning Objectives:

1. Discuss current treatment recommendations for infections and co-occurring conditions for patients presenting to clinical settings
2. Identify populations at risk for co-occurring conditions presenting to clinical settings
3. Describe how substance use disorder impacts the risk for co-occurring conditions
4. Explain how to screen clients for substance use disorder
5. Demonstrate effective team skills by sharing information effectively, listening and responding to feedback from others, and using simple communication

As a reminder, you must attend both days of the conference (Wednesday September 20th and Wednesday September 27th) and complete all required evaluations and steps to be eligible to receive continuing education credit. 

Origination Date: 9/20/2023
Expiration Date: 9/20/2025

In support of improving patient care, this activity has been planned and implemented by Centers for Disease Control and Prevention and STD/HIV Prevention Training Center at Johns Hopkins, MidAtlantic AIDS Education and Training Center, Central East Addiction Technology Transfer Center (Danya Institute), The Global Tuberculosis Institute. The Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CME: The Centers for Disease Control and Prevention designates this live activity for a maximum of 6.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAPA CME: Credit Designation Statement – Live The Centers for Disease Control and Prevention has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 6.25 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. 
 
CNE: The Centers for Disease Control and Prevention designates this activity for 6.25 nursing contact hours.

CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer .6 CEU's for this program.

CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES®) and/or Master Certified Health Education Specialists (MCHES®) to receive up to 6.5 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 6.5 Continuing Competency credits available are 6.5. CDC provider number 98614.

For Certified Public Health Professionals (CPH)

The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 7.0 CPH recertification credits for this program.

DISCLOSURE: In compliance with continuing education requirements, all planners and presenters must disclose all financial relationships, in any amount, with ineligible companies over the previous 24 months as well as any use of unlabeled product(s) or products under investigational use. 

CDC, our planners, and presenters wish to disclose they have no financial relationship(s) with ineligible companies with the exception of Dr. Matthew Hamill who wishes to disclose that he is a consultant with Roche Diagnostics and Chembio. He also was consulting on the preliminary development of an HSV Vaccine. Also Dr. Anthony Jaworski wishes to disclose that his spouse is employed by Baxter International, Inc. 

All of the relevant financial relationships listed for these individuals have been mitigated.

Content will not include any discussion of the unlabeled use of a product or a product under investigational use.

CDC did not accept financial or in-kind support from ineligible companies for this continuing education activity.

Questions?

Contact Jeanne Hoover of the STD/HIV PTC at 410-206-1156 or by email to jhoover6@jhmi.edu or the MidAtlantic AETC at maaetc@pitt.edu.  

As a reminder, you must attend both days of the conference (Wednesday September 20th and Wednesday September 27th) and complete all required evaluations and steps to be eligible to receive continuing education credit. 

Intended Audience

Physicians, nurse practitioners, nurse clinicians, physician assistants, health educators, outreach workers, social workers, health administrators, and other clinical personnel.

Contact